Royal Harbor Partners, LLC Amgen Inc Transaction History

Royal Harbor Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$229.03 - $291.01 $164,672 - $209,236	-719 Reduced 7.3%	9,134 $0
Q3 2022 Oct 21, 2022	SELL	$224.46 - $253.15 $20,425 - $23,036	-91 Reduced 0.92%	9,853 $2.22 Million
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $2.29 Million - $2.55 Million	9,944 New	9,944 $2.42 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Royal Harbor Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Royal Harbor Partners, LLC with notifications on news.